These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32261940)

  • 1. Amphiphilized poly(ethyleneimine) nanoparticles: a versatile multi-cargo carrier with enhanced tumor-homing efficiency and biocompatibility.
    Park S; Jeong K; Lee E; Lee JH; Yhee JY; Singh A; Koh J; Lee S; Kim K; Chan Kwon I; Park CR; Kim J; Kim S
    J Mater Chem B; 2015 Jan; 3(2):198-206. PubMed ID: 32261940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
    Lian H; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of functionalized nanoparticles with serum proteins and its impact on colloidal stability and cargo leaching.
    Abstiens K; Maslanka Figueroa S; Gregoritza M; Goepferich AM
    Soft Matter; 2019 Jan; 15(4):709-720. PubMed ID: 30624437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiphilic core-shell nanoparticles containing dense polyethyleneimine shells for efficient delivery of microRNA to Kupffer cells.
    Liu Z; Niu D; Zhang J; Zhang W; Yao Y; Li P; Gong J
    Int J Nanomedicine; 2016; 11():2785-97. PubMed ID: 27366061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
    Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negatively charged polypeptide-peptide nanoparticles showing efficient drug delivery to the mitochondria.
    Cohen-Erez I; Rapaport H
    Colloids Surf B Biointerfaces; 2018 Feb; 162():186-192. PubMed ID: 29190470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Raft-Mediated Membrane Tethering and Delivery of Hydrophobic Cargos from Liquid Crystal-Based Nanocarriers.
    Nag OK; Naciri J; Oh E; Spillmann CM; Delehanty JB
    Bioconjug Chem; 2016 Apr; 27(4):982-93. PubMed ID: 26974016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
    Le Droumaguet B; Nicolas J; Brambilla D; Mura S; Maksimenko A; De Kimpe L; Salvati E; Zona C; Airoldi C; Canovi M; Gobbi M; Magali N; La Ferla B; Nicotra F; Scheper W; Flores O; Masserini M; Andrieux K; Couvreur P
    ACS Nano; 2012 Jul; 6(7):5866-79. PubMed ID: 22725248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
    Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
    Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
    Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
    Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
    Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
    Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
    [No Abstract]   [Full Text] [Related]  

  • 16. Chelation, formulation, encapsulation, retention, and in vivo biodistribution of hydrophobic nanoparticles labelled with
    Hervella P; Dam JH; Thisgaard H; Baun C; Olsen BB; Høilund-Carlsen PF; Needham D
    J Control Release; 2018 Dec; 291():11-25. PubMed ID: 30291986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
    Zhang Y; Cui Z; Mei H; Xu J; Zhou T; Cheng F; Wang K
    Carbohydr Polym; 2019 Sep; 219():143-154. PubMed ID: 31151511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
    Choi KY; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Choi K; Jeong SY
    Biomaterials; 2011 Mar; 32(7):1880-9. PubMed ID: 21159377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
    Le Droumaguet B; Souguir H; Brambilla D; Verpillot R; Nicolas J; Taverna M; Couvreur P; Andrieux K
    Int J Pharm; 2011 Sep; 416(2):453-60. PubMed ID: 21251960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.